BioSpace News Archive

Can-Fite BioPharma Ltd today announced the Korean Intellectual Property Office has issued patent No. 10-1741281 titled, “Pharmaceutical Composition Comprising A3 Adenosine Receptor Agonist (IB-MECA/CF-101) For Treatment of Psoriasis” for the Company’s lead drug candidate Piclidenoson (CF101) in its psoriasis indication.

Verastem today announced payment of a $6 million milestone to Infinity Pharma, representing the first milestone under the duvelisib license agreement between Verastem and Infinity.

Ignyta, Inc. today announced that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation for entrectinib in the treatment of NTRK fusion-positive, locally advanced or metastatic solid tumours in adult and paediatric patients who have either progressed following prior therapies or who have no acceptable standard therapy.

GB Sciences has obtained the exclusive worldwide license to intellectual property covering a time-released cannabinoid formulation from the USE, the UCA, and the CIBERSAM.

Goldfinch Bio today announced collaborations with the Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to generate genomic data on over 1,500 patients with proteinuric kidney disease.

Dr. Chris Yu, CEO of international life sciences corporation Anpac Bio, announced this week the company set a new, international record, processing and reporting over 50,000 cases worldwide of the company’s proprietary, “Cancer Differentiation Analysis” (CDA) liquid biopsy tests.

Invitae is presenting data showing genetic sequencing and copy number variant (CNV) detection performed together using expert-curated panels offers better diagnosis rates over sequencing alone in patients with neuromuscular disorders and childhood epilepsy.

Eagle Pharmaceuticals today announced that the Company has been issued a new patent related to its RYANODEX formulation (dantrolene sodium) by the United States Patent and Trademark Office (USPTO).

Akonni Biosystems today announced it was chosen as a recipient for a challenge grant from the Bill & Melinda Gates Foundation.

Air Techniques, Inc., a leading innovator and manufacturer of dental equipment, has donated several boxes of their Monarch brand of Hand Sanitizer to the University of Puerto Rico School of Dental Medicine and the people it serves.